Abpro Holdings, Inc.

Abpro Holdings, Inc., trading under the ticker ACAB, is a blank-check company that filed a Form 10-Q with the SEC on May 20, 2022, under accession number 0001193125-22-156322, reflecting its status as a reporting SPAC during that period. The vehicle was organized to pursue an acquisition target in the biotechnology and life-sciences sector, consistent with the Abpro brand's emphasis on antibody-based therapeutics research. As of its May 2022 quarterly filing, the company remained in its search phase, continuing standard SPAC reporting obligations with the SEC. Investors and analysts tracking biotech-focused blank-check vehicles will find comprehensive filing history, timeline data, and deal-status updates for ACAB and hundreds of other SPACs by signing up for full access at SpacDesk.